Home
Conditions
Non-Hodgkin Lymphoma

Clinical trial condition

Non-Hodgkin Lymphoma

Explore clinical trials studying Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

214 public trials 63 recruiting studies

Refine in advanced search Browse all conditions

Non-Hodgkin Lymphoma trial results

Completed

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

NCT00556452

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +22 more
Locations: University of Michigan, Department of Internal Medicine, Blood and Marrow Transplant Program Ann Arbor, Michigan, United States

View Trial Details

Completed

Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)

NCT00644371

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: H. Santa Creu i Sant Pau. Barcelona, Barcelona., Spain

H. U. Marqués de Valdecilla. Santander, Cantabria, Spain

H.U. 12 de Octubre Madrid, Spain

H.U. Gregorio Marañón Madrid, Spain

View all 14 locations

View Trial Details

Completed

Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

NCT01900509

Conditions: Acute Leukemia, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

NCT01810120

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Hematologic Diseases, +17 more
Locations: Department of Oncology/Hematology of the Hospital Bambino Gesù (Roma) Rome, Italy

View Trial Details

Completed

Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies

NCT01871675

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations: The Colorado Blood Cancer Institute Denver, Colorado, United States

Florida Cancer Specialists Sarasota, Florida, United States

Oklahoma University Oklahoma City, Oklahoma, United States

Tennessee Oncology, PLLC Nashville, Tennessee, United States

View Trial Details

Completed

Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells

NCT00398411

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +26 more
Locations: Klinikum der Universität zu Köln Cologne, Germany

View Trial Details

Completed

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

NCT01344876

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +31 more
Locations: Nagoya, Japan

Tokyo, Japan

View Trial Details

Completed

A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma

NCT00103779

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Stanford University Stanford, California, United States

University of Miami Miami, Florida, United States

Cornell University New York, United States

View Trial Details

Completed

CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas

NCT00185965

Conditions: Bacterial Infections and Mycoses, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

EMD 521873 in Advanced Solid Tumors, MTD Finding

NCT01032681

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Universitäts-Klinikum Mainz III.Medizinische Klinik Mainz, Germany

Medizinische Klinik Universitätsklinikum Mannheim Medizinische Fakultät Mannheim Mannheim, Germany

Istituto Oncologico della Svizzera Italiana Ospedale Regionale Bellinzona e Valli (IOSI) Bellinzona, Switzerland

University of Lausanne Hospitals (CHUV) and Hospitals of Riveria-Chablais Lausanne, Switzerland

View Trial Details

Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma trial results

Related conditions